Gliclazide and Ogen 2.5 drug interactions - a phase IV clinical study of FDA data
Summary:
We study 28,135 people who take Gliclazide (gliclazide) and Ogen 2.5 (estropipate). There is no drug interaction reported.
The study analyzes what interactions people have when they take Gliclazide and Ogen 2.5. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Gliclazide?
Gliclazide has active ingredients of gliclazide. It is often used in diabetes. eHealthMe is studying from 28,131 Gliclazide users. Check the latest studies of Gliclazide.
What is Ogen 2.5?
Ogen 2.5 has active ingredients of estropipate. eHealthMe is studying from 4 Ogen 2.5 users. Check the latest studies of Ogen 2.5.
No report is found.
Do you take Gliclazide and Ogen 2.5?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Gliclazide (28,131 reports)
- Ogen 2.5 (4 reports)
How the study uses the data?
The study uses data from the FDA. It is based on gliclazide and estropipate (the active ingredients of Gliclazide and Ogen 2.5, respectively), and Gliclazide and Ogen 2.5 (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Maxalt and Scopolamine - 6 seconds ago
- Drug interactions of Azacitidine and Sulfasalazine - 6 seconds ago
- Drug interactions of Lanoxin and Calcium Citrate - 9 seconds ago
- Could Haloperidol cause High Blood Pressure? - 10 seconds ago
- Could Etodolac cause Face Oedema? - 22 seconds ago
- Could Lyrica cause Band Neutrophil Count Increased? - 41 seconds ago
- Drug interactions of Zyloprim and Sucralfate - 42 seconds ago
- Could Cromolyn Sodium cause Gallstones? - 46 seconds ago
- Iron Deficiency Anaemia and Blood Phosphorus Decreased - 46 seconds ago
- Could Cytomel cause Confusional State? - 51 seconds ago